Highlights
KLSE: TASCO (5140)       TASCO BHD MAIN : Transportation&Logistics
Last Price Today's Change   Day's Range   Trading Volume
4.06   +0.19 (4.91%)  3.85 - 4.08  2,714,300
Analyze this stock with MQ Trader system

Financials


Market Cap: 812 Million

Market Cap 812 Million
NOSH 200 Million

Latest Audited Result:  31-Mar-2020

Latest Audited Result: 31-Mar-2020
Announcement Date 17-Aug-2020
Next Audited Result: 31-Mar-2021
Est. Ann. Date: 17-Aug-2021
Est. Ann. Due Date: 27-Sep-2021

Latest Quarter:  31-Dec-2020 [#3]

Latest Quarter: 31-Dec-2020 [#3]
Announcement Date 27-Jan-2021
Next Quarter: 31-Mar-2021
Est. Ann. Date: 18-Jun-2021
Est. Ann. Due Date: 30-May-2021
QoQ | YoY   8.36%  |    198.89%

Annual (Unaudited) ( EPS: 4.45, P/E: 91.30 )

Revenue | NP to SH 747,438  |  8,891
RPS | P/RPS 373.82 Cent  |  1.09
EPS | P/E | EY 4.45 Cent  |  91.30  |  1.10%
DPS | DY | Payout % 2.00 Cent  |  0.49%  |  44.99%
NAPS | P/NAPS 2.18  |  1.86
YoY   -31.93%
NP Margin | ROE 1.33%  |  2.04%
F.Y. | Ann. Date 31-Mar-2020  |  18-Jun-2020

T4Q Result ( EPS: 12.28, P/E: 33.06 )

Revenue | NP to SH 836,964  |  24,558
RPS | P/RPS 418.59 Cent  |  0.97
EPS | P/E | EY 12.28 Cent  |  33.06  |  3.03%
DPS | DY | Payout % 4.00 Cent  |  0.99%  |  32.58%
NAPS | P/NAPS 2.27  |  1.79
QoQ | YoY   45.82%  |    115.27%
NP Margin | ROE 3.27%  |  5.41%
F.Y. | Ann. Date 31-Dec-2020  |  27-Jan-2021

Annualized Result ( EPS: 16.63, P/E: 24.42 )

Revenue | NP to SH 867,637  |  33,246
RPS | P/RPS 433.93 Cent  |  0.94
EPS | P/E | EY 16.63 Cent  |  24.42  |  4.10%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   24.63%  |    169.07%
NP Margin | ROE 4.15%  |  7.32%
F.Y. | Ann. Date 31-Dec-2020  |  27-Jan-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Mar-2019 27-Jan-2021 31-Dec-2020 3 242,706 16,701 12,188 11,597 - 453,882 - % 5.02% 2.56% 199,948 121.38 121.38 5.80 5.80 0.00 0.00 2.2700 2.27   8.36%   198.89% 31-Dec-2020 3.01 2.48 51.90 1.33 1.93% 0.00% 27-Jan-2021 4.06 3.34 70.00 1.79 1.43% 0.00%
31-Mar-2021 23-Oct-2020 30-Sep-2020 2 229,457 15,596 11,388 10,702 4,000 446,000 37.38% 4.96% 2.40% 200,000 114.73 114.76 5.35 5.35 2.00 2.00 2.2300 2.23   305.99%   160.71% 30-Sep-2020 1.42 1.24 26.54 0.64 3.77% 1.41% 23-Oct-2020 2.30 2.00 42.98 1.03 2.33% 0.87%
31-Mar-2021 26-Aug-2020 30-Jun-2020 1 178,565 5,229 3,406 2,636 - 434,000 - % 1.91% 0.61% 200,000 89.28 89.31 1.32 1.32 0.00 0.00 2.1700 2.17   799.20%   105.62% 30-Jun-2020 0.905 1.01 68.66 0.42 1.46% 0.00% 26-Aug-2020 0.85 0.95 64.49 0.39 1.55% 0.00%
31-Mar-2020 18-Jun-2020 31-Mar-2020 4 186,236 6,821 371 -377 4,000 436,000 - % 0.20% -0.09% 200,000 93.12 93.14 -0.19 -0.19 2.00 2.00 2.1800 2.18   -109.72%   -117.61% 31-Mar-2020 0.76 0.82 -403.18 0.35 -0.25% 2.63% 18-Jun-2020 0.905 0.97 -480.11 0.42 -0.21% 2.21%
31-Mar-2020 27-Feb-2020 31-Dec-2019 3 190,137 6,112 3,879 3,880 - 436,000 - % 2.04% 0.89% 200,000 95.07 95.09 1.94 1.94 0.00 0.00 2.1800 2.18   -5.48%   23.72% 31-Dec-2019 1.20 1.26 61.86 0.55 1.62% 0.00% 27-Feb-2020 1.11 1.17 57.22 0.51 1.75% 0.00%
31-Mar-2020 21-Nov-2019 30-Sep-2019 2 190,663 5,743 4,265 4,105 - 432,000 - % 2.24% 0.95% 200,000 95.33 95.36 2.05 2.05 0.00 0.00 2.1600 2.16   220.20%   51.25% 30-Sep-2019 1.05 1.10 51.16 0.49 1.95% 0.00% 21-Nov-2019 1.16 1.22 56.52 0.54 1.77% 0.00%
31-Mar-2020 22-Aug-2019 30-Jun-2019 1 180,402 1,921 1,390 1,282 - 428,000 - % 0.77% 0.30% 200,000 90.20 90.22 0.64 0.64 0.00 0.00 2.1400 2.14   -40.12%   -74.72% 28-Jun-2019 1.33 1.47 207.49 0.62 0.48% 0.00% 22-Aug-2019 1.20 1.33 187.21 0.56 0.53% 0.00%
31-Mar-2019 29-May-2017 31-Mar-2019 4 179,374 3,872 2,218 2,141 - 372,000 - % 1.24% 0.58% 200,000 89.69 89.71 1.07 1.07 0.00 0.00 1.8600 1.86   -31.73%   -57.51% 29-Mar-2019 1.66 1.85 155.07 0.89 0.64% 0.00% 29-May-2019 1.34 1.49 125.18 0.72 0.80% 0.00%
31-Mar-2019 21-Feb-2019 31-Dec-2018 3 184,694 4,372 3,205 3,136 - 368,000 - % 1.74% 0.85% 200,000 92.35 92.37 1.57 1.57 0.00 0.00 1.8400 1.84   15.55%   -61.63% 31-Dec-2018 1.00 1.08 63.78 0.54 1.57% 0.00% 21-Feb-2019 1.36 1.47 86.73 0.74 1.15% 0.00%
31-Mar-2019 15-Nov-2018 30-Sep-2018 2 191,098 3,647 2,789 2,714 - 364,000 - % 1.46% 0.75% 200,000 95.55 95.57 1.36 1.36 0.00 0.00 1.8200 1.82   -46.48%   -70.31% 28-Sep-2018 1.59 1.66 117.17 0.87 0.85% 0.00% 15-Nov-2018 1.24 1.30 91.38 0.68 1.09% 0.00%
31-Mar-2019 16-Aug-2018 30-Jun-2018 1 181,635 6,768 5,168 5,071 - 364,000 - % 2.85% 1.39% 200,000 90.82 90.84 2.54 2.54 0.00 0.00 1.8200 1.82   0.64%   -28.01% 29-Jun-2018 1.70 1.87 67.05 0.93 1.49% 0.00% 16-Aug-2018 1.72 1.89 67.84 0.95 1.47% 0.00%
31-Mar-2018 24-May-2018 31-Mar-2018 4 169,501 9,636 5,100 5,039 5,000 359,999 99.23% 3.01% 1.40% 200,000 84.75 84.77 2.52 2.52 2.50 2.50 1.8000 1.80   -38.35%   -33.03% 30-Mar-2018 1.67 1.97 66.28 0.93 1.51% 1.50% 24-May-2014 1.93 2.28 76.60 1.07 1.31% 1.30%
31-Mar-2018 09-Feb-2018 31-Dec-2017 3 191,660 10,960 8,249 8,173 4,000 361,999 48.94% 4.30% 2.26% 200,000 95.83 95.85 4.09 4.09 2.00 2.00 1.8100 1.81   -10.60%   -9.30% 29-Dec-2017 2.08 2.17 50.90 1.15 1.96% 0.96% 09-Jun-2014 1.99 2.08 48.70 1.10 2.05% 1.01%
31-Mar-2018 16-Nov-2014 30-Sep-2017 2 192,089 11,905 9,197 9,142 - 351,999 - % 4.79% 2.60% 200,000 96.04 96.07 4.57 4.57 0.00 0.00 1.7600 1.76   29.78%   12.52% 29-Sep-2017 2.34 2.44 51.19 1.33 1.95% 0.00% 16-Nov-2017 2.37 2.47 51.85 1.35 1.93% 0.00%
31-Mar-2018 17-Aug-2017 30-Jun-2017 1 156,959 9,502 7,111 7,044 - 348,000 - % 4.53% 2.02% 200,000 78.48 78.50 3.52 3.52 0.00 0.00 1.7400 1.74   -6.38%   17.22% 30-Jun-2017 2.40 3.06 68.14 1.38 1.47% 0.00% 17-Aug-2017 2.45 3.12 69.56 1.41 1.44% 0.00%
31-Mar-2017 20-Jun-2013 31-Mar-2017 4 147,392 12,170 7,556 7,524 5,000 340,000 66.45% 5.13% 2.21% 200,000 73.70 73.72 3.76 3.76 2.50 2.50 1.7000 1.70   -16.50%   -11.07% 31-Mar-2017 2.16 2.93 57.42 1.27 1.74% 1.16% 26-May-2017 2.52 3.42 66.99 1.48 1.49% 0.99%
31-Mar-2017 23-Feb-2017 31-Dec-2016 3 159,194 12,314 9,054 9,011 4,000 338,000 44.39% 5.69% 2.67% 200,000 79.60 79.62 4.51 4.51 2.00 2.00 1.6900 1.69   10.90%   0.54% 30-Dec-2016 1.50 1.88 33.29 0.89 3.00% 1.33% 23-Feb-2017 1.74 2.19 38.62 1.03 2.59% 1.15%
31-Mar-2013 16-Nov-2016 30-Sep-2016 2 148,126 10,896 8,166 8,125 - 327,999 - % 5.51% 2.48% 200,000 74.06 74.08 4.06 4.06 0.00 0.00 1.6400 1.64   35.21%   14.50% 30-Sep-2016 1.52 2.05 37.42 0.93 2.67% 0.00% 11-May-2012 1.50 2.03 36.92 0.91 2.71% 0.00%
31-Mar-2017 17-Aug-2016 30-Jun-2016 1 129,690 8,148 6,080 6,009 - 325,999 - % 4.69% 1.84% 200,000 64.85 64.86 3.00 3.01 0.00 0.00 1.6300 1.63   -28.98%   -1.28% 30-Jun-2016 1.55 2.39 51.59 0.95 1.94% 0.00% 17-Aug-2016 1.52 2.34 50.59 0.93 1.98% 0.00%
31-Mar-2016 27-May-2016 31-Mar-2016 4 125,274 14,436 8,497 8,461 5,000 320,000 59.09% 6.78% 2.64% 200,000 62.64 62.65 4.23 4.23 2.50 2.50 1.6000 1.60   -5.60%   51.98% 31-Mar-2016 1.59 2.54 37.58 0.99 2.66% 1.57% 27-May-2016 1.59 2.54 37.58 0.99 2.66% 1.57%
31-Mar-2016 24-Feb-2016 31-Dec-2015 3 143,670 11,786 8,969 8,963 4,000 316,000 44.63% 6.24% 2.84% 200,000 71.84 71.85 4.48 4.48 2.00 2.00 1.5800 1.58   26.31%   26.95% 31-Dec-2015 1.70 2.37 37.93 1.08 2.64% 1.18% 24-Feb-2016 1.52 2.12 33.92 0.96 2.95% 1.32%
31-Mar-2016 12-Nov-2015 30-Sep-2015 2 127,878 9,591 7,121 7,096 - 306,999 - % 5.57% 2.31% 100,000 127.88 63.96 7.10 3.55 0.00 0.00 3.0700 1.54   16.58%   -12.23% 30-Sep-2015 3.60 2.82 50.73 1.17 1.97% 0.00% 12-Nov-2015 1.86 1.45 26.21 0.61 3.82% 0.00%
31-Mar-2016 12-Aug-2015 30-Jun-2015 1 118,844 8,269 6,123 6,087 - 303,999 - % 5.15% 2.00% 100,000 118.84 59.44 6.09 3.04 0.00 0.00 3.0400 1.52   9.34%   -38.94% 30-Jun-2015 3.97 3.34 65.22 1.31 1.53% 0.00% 12-Aug-2015 3.88 3.26 63.74 1.28 1.57% 0.00%
14-Feb-2011 18-May-2015 31-Mar-2015 4 114,249 7,529 5,589 5,567 5,000 299,000 89.81% 4.89% 1.86% 100,000 114.25 57.14 5.57 2.78 5.00 2.50 2.9900 1.50   -21.15%   9.59% 31-Mar-2015 3.53 3.09 63.41 1.18 1.58% 1.42% 18-May-2015 4.32 3.78 77.60 1.44 1.29% 1.16%
31-Mar-2015 11-Feb-2015 31-Dec-2014 3 122,639 9,728 7,098 7,060 4,000 297,000 56.66% 5.79% 2.38% 100,000 122.64 61.34 7.06 3.53 4.00 2.00 2.9700 1.49   -12.68%   -14.58% 31-Dec-2014 2.78 2.27 39.38 0.94 2.54% 1.44% 11-Feb-2015 3.07 2.50 43.48 1.03 2.30% 1.30%
31-Mar-2015 18-Nov-2014 30-Sep-2010 2 122,615 10,890 8,111 8,085 - 290,000 - % 6.62% 2.79% 100,000 122.62 61.32 8.09 4.04 0.00 0.00 2.9000 1.45   -18.90%   16.82% 30-Sep-2014 3.40 2.77 42.05 1.17 2.38% 0.00% 18-Nov-2014 3.06 2.50 37.85 1.06 2.64% 0.00%
31-Mar-2015 06-Aug-2014 30-Jun-2014 1 134,802 13,306 10,000 9,969 - 286,999 - % 7.42% 3.47% 100,000 134.80 67.42 9.97 4.99 0.00 0.00 2.8700 1.44   96.24%   73.98% 30-Jun-2014 2.60 1.93 26.08 0.91 3.83% 0.00% 06-Aug-2014 2.57 1.91 25.78 0.90 3.88% 0.00%
31-Mar-2014 21-May-2014 31-Mar-2014 4 116,082 8,466 5,102 5,080 5,000 276,999 98.43% 4.40% 1.83% 100,000 116.08 58.06 5.08 2.54 5.00 2.50 2.7700 1.39   -38.54%   15.11% 31-Mar-2009 2.50 2.15 49.21 0.90 2.03% 2.00% 21-May-2014 2.57 2.21 50.59 0.93 1.98% 1.95%
31-Mar-2014 18-Feb-2014 31-Dec-2009 128,123 10,731 8,290 8,265 - 273,000 - % 6.47% 3.03% 100,000 128.12 64.08 8.27 4.13 0.00 0.00 2.7300 1.37   19.42%   6.11% 31-Dec-2013 2.09 1.63 25.29 0.77 3.95% 0.00% 18-Feb-2014 2.12 1.65 25.65 0.78 3.90% 0.00%
31-Mar-2014 14-Nov-2013 30-Sep-2013 2 118,051 9,369 6,939 6,921 50 268,000 0.72% 5.88% 2.58% 100,000 118.05 59.04 6.92 3.46 0.05 0.03 2.6800 1.34   20.79%   -4.30% 30-Sep-2013 2.00 1.69 28.90 0.75 3.46% 0.03% 14-Nov-2013 2.11 1.79 30.49 0.79 3.28% 0.02%
31-Dec-2013 19-Aug-2013 30-Jun-2013 1 104,324 7,538 5,747 5,730 - 260,999 - % 5.51% 2.20% 100,000 104.32 52.18 5.73 2.87 0.00 0.00 2.6100 1.31   29.84%   -19.35% 28-Jun-2013 2.15 2.06 37.52 0.82 2.67% 0.00% 19-Aug-2013 2.16 2.07 37.70 0.83 2.65% 0.00%
31-Dec-2013 13-May-2013 31-Mar-2013 1 93,033 5,957 4,434 4,413 - 259,999 - % 4.77% 1.70% 100,000 93.03 46.53 4.41 2.21 0.00 0.00 2.6000 1.30   -43.34%   -34.75% 29-Oct-2009 2.03 2.18 46.00 0.78 2.17% 0.00% 13-May-2013 2.39 2.57 54.16 0.92 1.85% 0.00%
31-Dec-2012 21-Feb-2013 31-Dec-2012 104,463 6,883 7,811 7,789 12,010 254,999 154.19% 7.48% 3.05% 100,000 104.46 52.25 7.79 3.90 12.01 6.01 2.5500 1.28   7.70%   -44.22% 31-Dec-2012 2.00 1.91 25.68 0.78 3.89% 6.01% 21-Feb-2013 2.03 1.94 26.06 0.80 3.84% 5.92%
31-Dec-2012 22-Nov-2012 30-Sep-2012 112,191 9,934 7,256 7,232 - 251,999 - % 6.47% 2.87% 100,000 112.19 56.11 7.23 3.62 0.00 0.00 2.5200 1.26   1.79%   2.12% 28-Sep-2012 2.04 1.82 28.21 0.81 3.55% 0.00% 22-Nov-2012 2.00 1.78 27.65 0.79 3.62% 0.00%
31-Dec-2012 08-Aug-2012 30-Jun-2012 2 107,899 9,392 7,125 7,105 - 244,827 - % 6.60% 2.90% 99,929 107.97 53.96 7.11 3.55 0.00 0.00 2.4500 1.22   5.06%   0.35% 29-Jun-2012 2.07 1.92 29.11 0.84 3.43% 0.00% 08-Aug-2012 2.18 2.02 30.66 0.89 3.26% 0.00%
31-Dec-2012 03-May-2012 31-Mar-2012 117,895 9,106 6,784 6,763 - 248,110 - % 5.75% 2.73% 100,044 117.84 58.96 6.76 3.38 0.00 0.00 2.4800 1.24   -51.56%   4.61% 30-Mar-2012 2.05 0.00 0.00 1.03 0.00% 0.00% 03-Sep-2009 2.17 0.00 0.00 1.09 0.00% 0.00%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 113,870 9,572 13,991 13,963 12,902 241,051 92.41% 12.29% 5.79% 100,021 113.85 56.95 13.96 6.98 12.90 6.45 2.4100 1.21   97.16%   64.83% 30-Dec-2011 1.62 1.42 11.60 0.67 8.62% 7.96% 22-Feb-2012 1.85 1.63 13.25 0.77 7.55% 6.97%
31-Dec-2011 09-Nov-2011 30-Sep-2011 3 129,556 9,892 7,103 7,082 - 206,058 - % 5.48% 3.44% 100,028 129.52 64.79 7.08 3.54 0.00 0.00 2.0600 1.03   0.03%   32.57% 30-Sep-2011 1.47 1.13 20.76 0.71 4.82% 0.00% 09-Nov-2011 1.59 1.23 22.46 0.77 4.45% 0.00%
31-Dec-2011 10-Aug-2011 30-Jun-2011 2 107,422 9,295 7,097 7,080 - 220,000 - % 6.61% 3.22% 100,000 107.42 53.72 7.08 3.54 0.00 0.00 2.2000 1.10   9.51%   3.78% 30-Jun-2011 1.50 1.40 21.19 0.68 4.72% 0.00% 10-Aug-2011 1.50 1.40 21.19 0.68 4.72% 0.00%
31-Dec-2011 23-May-2011 31-Mar-2011 1 118,363 8,605 6,485 6,465 - 219,829 - % 5.48% 2.94% 99,922 118.45 59.20 6.47 3.23 0.00 0.00 2.2000 1.10   -23.68%   56.12% 31-Mar-2011 1.60 1.35 24.73 0.73 4.04% 0.00% 23-May-2011 1.66 1.40 25.66 0.75 3.90% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.
  3 people like this.
 
NPRA1985 500 million vaccine doses in Q1 2021 closer to reality, says WHO

https://www.freemalaysiatoday.com/category/world/2020/12/05/500-million-vaccine-doses-in-q1-2021-closer-to-reality-says-who/
05/12/2020 2:41 PM
MNawar https://asia.nikkei.com/Spotlight/Coronavirus/World-rushes-to-build-ultra-cold-networks-to-deliver-COVID-vaccines
05/12/2020 3:21 PM
Michael Kwok Recommend sell rm 2.57.Reality stage say not all vaccines need cold storages.
06/12/2020 11:18 PM
Value888 justed added more. Logistics business posting strong V growth.
07/12/2020 9:23 AM
dcba 2.4 seems critical support.. Broken kalu heavy volume, cut loss?
07/12/2020 9:28 AM
Michael Kwok Vaccines is small thing.Not like Malaysian exporting Boeing or Airbus plane few thousand plane per year.Thn Malaysian is shortage of logistic vehicle.Dear.Please use the head.
07/12/2020 4:30 PM
Value888 Logistics going at full force. Target RM4
08/12/2020 2:26 PM
troy88 Something big is brewing. Big lots swallowed up by big fish!
08/12/2020 3:56 PM
Dartmaster GET THE HELL ON BOARD GUYS. COLD CHAIN IS VERY VERY IMPORTANT FOR ALL VACCINE INCLUDING CHINA . LOOK AT INDONESIA EVEN CHINA VACCINES NEEDS COLD CHAIN TRANPORTATION AND STORAGE!
08/12/2020 4:08 PM
NewStockerBuz tmr this will go up somehow as gdex having mou with them
i have both gdex and tasco
hope tmr is myday
was holding since june
08/12/2020 8:20 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V
09/12/2020 3:23 PM
CalvinKang sky is the limit for tasco
09/12/2020 4:07 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c
09/12/2020 10:32 PM
NPRA1985 Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.

The vaccine and other products are developed by state-owned China National Pharmaceutical Group Corp (Sinopharm).

In a filing with Bursa Malaysia today, Kanger said it has entered into a memorandum of understanding (MoU) with Zuellig Pharma, the largest vaccine distributor in Malaysia and in Asia, to facilitate the import, warehousing and distribution of Covid-19 vaccines in Malaysia.

Separately, Kanger announced that it has also entered into an MoU with K-Star to appoint the latter as the sales agent of Covid-19 vaccines for private clinics in Malaysia.

Kanger said both MoUs will add value to the group as it is now focused on expanding its business into the healthcare industry, which includes the distribution of Covid-19 vaccines, and is looking for a well-established logistics and distribution provider.

https://www.theedgemarkets.com/article/kanger-ropes-more-collaborators-help-distribute-covid19-vaccines
09/12/2020 11:15 PM
wolfofWS those who already on boat sit tight tight watch show with ur porncorn

those who not yet get ur tickets last call for now, anything below RM3.50 sapu kuat kuat

stg brewing and big coming,RM5 is the tp mark my words,now or never u make ur own choice~
10/12/2020 9:30 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/
10/12/2020 11:55 PM
Dakewlest Can still in?
11/12/2020 12:47 AM
NPRA1985 FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar

(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.

The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.

"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.

https://edition.cnn.com/2020/12/11/health/us-coronavirus-friday/index.html
12/12/2020 2:28 AM
NPRA1985 Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization
12/12/2020 3:00 PM
NPRA1985 Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/
12/12/2020 6:01 PM
wolfofWS https://www.thestar.com.my/news/nation/2020/12/13/govt-plans-to-increase-covid-19-vaccine-order-to-cover-60-70pct-of-m039sians-says-muhyiddin

Are you guys ready for the kaboom?
13/12/2020 4:11 PM
NPRA1985 Bahrain Approves China’s Sinopharm Covid-19 Vaccine

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

https://abcnews.go.com/Health/wireStory/bahrain-approves-chinese-covid-19-vaccine-74699175
13/12/2020 5:58 PM
NPRA1985 Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM

The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.

Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.

“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.

https://www.theedgemarkets.com/article/govt-mulls-increasing-covid19-vaccine-purchase-30-6070-meet-msians-immunisation-needs-%E2%80%94-pm
13/12/2020 6:27 PM
NPRA1985 COVID-19 vaccine is permissible for Muslim use, preservation of life is key consideration: MUIS

SINGAPORE: The Islamic Religious Council of Singapore (MUIS) said on Sunday (Dec 13) that it "holds the position that a COVID-19 vaccine is permissible for Muslim use".

"We would advise and encourage Muslims to be vaccinated once it is available and when the vaccine has been medically authorised as safe and effective, as this is a basic necessity to protect lives in the context of a global pandemic," said MUIS.

The council made its religious position on the vaccine known in a media release.

It said that the objectives of introducing a COVID-19 vaccine and the processes involved in producing vaccines are "largely aligned to established Islamic principles and values".

Islamic jurisprudence places great importance on the sanctity and safety of human life and the protection of livelihoods, it said.

Efforts to protect human life from any form of danger and harm, such as the development of vaccines, are therefore highly encouraged in Islam, it added.

https://www.channelnewsasia.com/news/singapore/covid-19-vaccine-muis-permissible-for-muslim-use-halal-13762806
13/12/2020 8:19 PM
Woodswater https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

Tanah Malayu?
14/12/2020 8:45 AM
inikalilah888 this counter can collect? Drop so much recently
18/12/2020 10:30 AM
satha44 Tomorrow should b a good day.....hopefully
21/12/2020 11:48 PM
realdeal46 Demand for cold storage facilities grows with e-commerce popularity

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/12/21/demand-for-cold-storage-facilities-grows-with-e-commerce-popularity

“There has been a spike in short-term logistics requirements directly linked to the immediate impact of the pandemic, particularly in relation to the significant expansion of online grocery spending, and the need to support critical health services such as vaccines distribution.”

Since all leading vaccines require very low temperatures to remain effective, cold storage for the new COVID-19 vaccines might be the next big thing in the supply chain and logistics industry.
22/12/2020 10:40 AM
inikalilah888 Wow...engine sudah panas
28/12/2020 3:23 PM
newbie9893 Tasco might limit up today
28/12/2020 3:35 PM
kanzaki123 PE so low o..
30/12/2020 3:17 PM
amtheng https://www.theedgemarkets.com/article/tasco-gdex-partnership-winwin-say-senior-executives
03/01/2021 1:34 PM
amtheng In Malaysia, we are handling the air freight clearance and local delivery to the designated warehouse for AstraZeneca.
03/01/2021 1:35 PM
StockHunters NATWIDE coming soon, news to be released!
collect while it's still low :)
07/01/2021 10:21 PM
ikenduit Tasco with GDex for last mile delivery
13/01/2021 9:11 PM
paksaham today RHB report TP 4.75. anyone has a copy can share?
18/01/2021 5:09 PM
paksaham thank you sir
18/01/2021 7:31 PM
007bursa This counter tp at least rm6
18/01/2021 11:56 PM
3101575000 Qrt results will be very good n release soon
22/01/2021 9:38 PM
amtheng Share split 1 into 4...just announced...TP 4.75 coming soon
25/01/2021 10:38 PM
winston1 share split to 4 announced
25/01/2021 10:44 PM
porklamb https://www.klsescreener.com/v2/announcements/view/3297789 gogogo
25/01/2021 11:28 PM
Dragon88 why share price drop quite a lot today , any idea ?
26/01/2021 10:40 AM
ernest60 i think stock split no attractive lor...
26/01/2021 10:59 AM
ml2020 @Dragon88 down 0.02 cents (barely half a %) is a "drop a lot" to you ?
26/01/2021 10:26 PM
porklamb Rocket launch soon
27/01/2021 10:33 AM
troy88 Will break 4 soon and not look back.
27/01/2021 10:53 AM
chshzhd rev 243m pbt 16.7m
27/01/2021 6:38 PM
chshzhd annualize pe 18
27/01/2021 6:39 PM
Jokers2020 price already factor in as i believe insider already know the good QR profit
27/01/2021 9:44 PM